IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES

Latest 424B1 SEC Filings
Prospectus [Rule 424(b)(1)]

NORTH AMERICAN SCIENTIFIC INC, 424B1, 2000-12-14
EPOCH PHARMACEUTICALS INC, 424B1, 2000-08-02
AVIGEN INC \DE, 424B1, 2000-04-13
AQUILA BIOPHARMACEUTICALS INC, 424B1, 1999-07-30
ALLIANCE PHARMACEUTICAL CORP, 424B1, 1999-06-03
ALLIANCE PHARMACEUTICAL CORP, 424B1, 1999-01-07
DYNAGEN INC, 424B1, 1997-12-16
EPIX MEDICAL INC, 424B1, 1997-11-12
ZYMETX INC, 424B1, 1997-10-30
HUMAN GENOME SCIENCES INC, 424B1, 1997-03-14
EPIX MEDICAL INC, 424B1, 1997-01-30
DYNAGEN INC, 424B1, 1997-01-15
DADE INTERNATIONAL INC, 424B1, 1996-11-01
NEOGEN CORP, 424B1, 1996-10-23
MERIDIAN DIAGNOSTICS INC, 424B1, 1996-09-25
T CELL SCIENCES INC, 424B1, 1996-08-28
CENTOCOR INC, 424B1, 1996-07-11
DIATIDE INC, 424B1, 1996-06-14
BIOSOURCE INTERNATIONAL INC, 424B1, 1996-05-31
MOLECULAR BIOSYSTEMS INC, 424B1, 1996-05-24
MERIDIAN DIAGNOSTICS INC, 424B1, 1996-05-15
ALLIANCE PHARMACEUTICAL CORP, 424B1, 1996-04-04
CENTOCOR INC, 424B1, 1996-03-12


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission